Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-Current Debt (2018 - 2025)

TELA Bio has reported Non-Current Debt over the past 7 years, most recently at $55.7 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $55.7 million for Q4 2025, up 35.33% from a year ago — trailing twelve months through Dec 2025 was $55.7 million (up 35.33% YoY), and the annual figure for FY2025 was $55.7 million, up 35.33%.
  • Non-Current Debt for Q4 2025 was $55.7 million at TELA Bio, up from $41.5 million in the prior quarter.
  • Over the last five years, Non-Current Debt for TELA hit a ceiling of $55.7 million in Q4 2025 and a floor of $31.5 million in Q4 2021.
  • Median Non-Current Debt over the past 5 years was $40.4 million (2023), compared with a mean of $40.7 million.
  • Peak annual rise in Non-Current Debt hit 35.33% in 2025, while the deepest fall reached 6.78% in 2025.
  • TELA Bio's Non-Current Debt stood at $31.5 million in 2021, then grew by 26.75% to $39.9 million in 2022, then increased by 1.5% to $40.5 million in 2023, then increased by 1.5% to $41.1 million in 2024, then soared by 35.33% to $55.7 million in 2025.
  • The last three reported values for Non-Current Debt were $55.7 million (Q4 2025), $41.5 million (Q3 2025), and $38.1 million (Q2 2025) per Business Quant data.